Profile: Strategic BioSolutions focuses on polyclonal antibody production, monoclonal antibody production and genomic antibody technology. We offer polyclonal antibodies from many different species. We develop immunoassays for the diagnostics, pharmaceutical, environmental, and agricultural markets. We also offer immunoassay formats and platforms from high-throughput laboratory tests to field-ready immunoassays. Our human cardiac troponin I is a specific diagnostic marker of acute myocardial infarction.